Cancer cells employ lipid droplets to survive toxic stress
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Cancer cells surviving chemotherapy show increased lipid droplets (LDs) that protect them. Inhibiting LD formation with DGAT1 inhibitors alongside chemotherapy can enhance cancer cell death.
Area Of Science
- Oncology
- Cell Biology
- Biochemistry
Background
- Lipid reprogramming fuels cancer cell proliferation and progression.
- Elevated lipid droplets (LDs) are linked to aggressive prostate cancer (PCa) and treatment resistance.
- LDs may protect cells from lipotoxicity and lipid peroxidation.
Purpose Of The Study
- Investigate the role of LDs in prostate cancer (PCa) survival and treatment response.
- Determine if LDs contribute to chemotherapy resistance in cancer cells.
- Explore novel therapeutic strategies targeting LDs in PCa.
Main Methods
- Quantified LDs in PCa cells using staining, imaging, and flow cytometry.
- Performed lipidomics and metabolomics on control and surviving cancer cells.
- Analyzed public datasets for clinical relevance of LD-related data.
Main Results
- Chemotherapy-surviving prostate and breast cancer cells exhibited elevated LDs.
- Increased LDs correlated with higher reactive oxygen species (ROS) levels, sequestering damaged lipids.
- Inhibiting DGAT1 (diacylglycerol O-acyltransferase 1) alongside chemotherapy reduced LDs and increased cancer cell death.
Conclusions
- Elevated LDs promote cancer cell survival during chemotherapy by managing oxidative stress.
- Combination therapy with DGAT1 inhibitors and chemotherapy shows potential for increasing cancer cell death.
- Targeting LD biogenesis offers a promising strategy for overcoming treatment resistance in prostate cancer.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...